Patents by Inventor Qiaohong WEI

Qiaohong WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Match-paired monoclonal antibodies against MRJP4, ELISA kit and colloidal gold immunoassay test strip for detecting MRJP4
    Patent number: 11693008
    Abstract: Match-paired monoclonal antibodies against major royal jelly protein 4 (MRJP4) are secreted by hybridoma cell lines having microbial deposit numbers of CGMCC No. 17294 and CGMCC No. 17295, which are used in an ELISA kit and a colloidal gold immunoassay strip for detecting the MRJP4. The positive and MRJP4-specific cell lines are obtained by cell fusion using an antigen of MRJP4 recombinant protein and a cross-reaction with other major royal jelly proteins. The MRJP4 recombinant protein is used as an antigen to obtain several positive cell lines by cell fusion and two MRJP4-specific fusion cell lines are obtained by a cross-reaction with other major royal jelly proteins. Primary screening of a matched antibody pair is performed according to antibody pairing for recognizing different epitopes.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: July 4, 2023
    Assignee: Institute of Apicultural Research, Chinese Academy of Agricultural Sciences
    Inventors: Han Hu, Qiaohong Wei, Si Chen, Mao Feng, Lifeng Meng, Bin Han, Yu Fang, Chuan Ma, Jianke Li
  • Match-paired Monoclonal Antibodies against MRJP4, ELISA Kit and Colloidal Gold Immunoassay Test Strip for Detecting MRJP4
    Publication number: 20200292547
    Abstract: Match-paired monoclonal antibodies against major royal jelly protein 4 (MRJP4) are secreted by hybridoma cell lines having microbial deposit numbers of CGMCC No. 17294 and CGMCC No. 17295, which are used in an ELISA kit and a colloidal gold immunoassay strip for detecting the MRJP4. The positive and MRJP4-sepcific cell lines are obtained by cell fusion using an antigen of MRJP4 recombinant protein and a cross-reaction with other major royal jelly proteins. The MRJP4 recombinant protein is used as an antigen to obtain several positive and cell lines by cell fusion and twoMRJP4-specific fusion cell lines are obtained by a cross-reaction with other major royal jelly proteins. Primary screening of a matched antibody pair is performed according to antibody pairing for recognizing different epitopes.
    Type: Application
    Filed: January 28, 2020
    Publication date: September 17, 2020
    Applicant: Institute of Apicultural Research, Chinese Academy of Agricultural Sciences
    Inventors: Han HU, Qiaohong WEI, Si CHEN, Mao FENG, Lifeng MENG, Bin HAN, Yu FANG, Chuan MA, Jianke LI